Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials

BACKGROUND: Epstein–Barr virus positivity (EBV+) and microsatellite instability (MSI-high) are positive prognostic factors for survival in resectable gastric cancer (GC). However, benefit of perioperative treatment in patients with MSI-high tumors remains topic of discussion. Here, we present the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Biesma, Hedde D., Soeratram, Tanya T. D., Sikorska, Karolina, Caspers, Irene A., van Essen, Hendrik F., Egthuijsen, Jacqueline M. P., Mookhoek, Aart, van Laarhoven, Hanneke W. M., van Berge Henegouwen, Mark I., Nordsmark, Marianne, van der Peet, Donald L., Warmerdam, Fabienne A. R. M., Geenen, Maud M., Loosveld, Olaf J. L., Portielje, Johanneke E. A., Los, Maartje, Heideman, Daniëlle A. M., Meershoek-Klein Kranenbarg, Elma, Hartgrink, Henk H., van Sandick, Johanna, Verheij, Marcel, van de Velde, Cornelis J. H., Cats, Annemieke, Ylstra, Bauke, van Grieken, Nicole C. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013342/
https://www.ncbi.nlm.nih.gov/pubmed/35129727
http://dx.doi.org/10.1007/s10120-022-01280-2

Ejemplares similares

Ejemplares similares